Ralliant Corporation $RAL Shares Bought by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP grew its holdings in Ralliant Corporation (NYSE:RAL) by 278.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 179,891 shares of the company’s stock after buying an additional 132,403 shares during the quarter. Hudson Bay Capital Management LP’s holdings in Ralliant were worth $7,867,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the business. Arizona State Retirement System grew its holdings in Ralliant by 1.2% during the third quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock worth $1,468,000 after acquiring an additional 413 shares during the period. Manchester Capital Management LLC purchased a new position in Ralliant in the second quarter worth $29,000. Choreo LLC lifted its holdings in Ralliant by 9.9% in the third quarter. Choreo LLC now owns 6,063 shares of the company’s stock valued at $265,000 after acquiring an additional 546 shares during the period. Westfuller Advisors LLC purchased a new stake in shares of Ralliant during the 3rd quarter worth $26,000. Finally, Palisade Asset Management LLC purchased a new stake in shares of Ralliant during the 3rd quarter worth $26,000.

Insider Transactions at Ralliant

In related news, SVP Amir A. Kazmi acquired 2,545 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was bought at an average price of $39.27 per share, with a total value of $99,942.15. Following the purchase, the senior vice president directly owned 39,699 shares in the company, valued at $1,558,979.73. The trade was a 6.85% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Kevin E. Bryant acquired 1,250 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were bought at an average price of $39.97 per share, for a total transaction of $49,962.50. Following the completion of the acquisition, the director owned 4,653 shares in the company, valued at approximately $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 8,145 shares of company stock worth $332,233 in the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on RAL shares. Royal Bank Of Canada cut their price target on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Truist Financial decreased their price objective on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a report on Friday, February 6th. Barclays lowered their target price on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research report on Friday, February 6th. Finally, Oppenheimer decreased their price target on Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $50.50.

Ralliant Stock Down 4.2%

RAL stock opened at $40.78 on Friday. The company has a 50 day moving average price of $47.29 and a two-hundred day moving average price of $46.70. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a market capitalization of $4.56 billion and a P/E ratio of 20.81. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. Ralliant’s revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a yield of 0.5%. Ralliant’s dividend payout ratio is 10.20%.

Ralliant Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.